{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T04:52:31Z","timestamp":1789707151196,"version":"4.0.1"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsubstanceabusetreatment.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Abuse Treatment"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.jsat.2020.108061","type":"journal-article","created":{"date-parts":[[2020,6,22]],"date-time":"2020-06-22T23:04:43Z","timestamp":1592867083000},"page":"108061","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Benzodiazepine misuse in adults with alcohol use disorder: Prevalence, motives and patterns of use"],"prefix":"10.1016","volume":"117","author":[{"given":"R. Kathryn","family":"McHugh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria R.","family":"Votaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine R.","family":"Taghian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret L.","family":"Griffin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger D.","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jsat.2020.108061_bb0005","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.7399","article-title":"Patterns in outpatient benzodiazepine prescribing in the United States","volume":"2","author":"Agarwal","year":"2019","journal-title":"JAMA Network Open"},{"issue":"4","key":"10.1016\/j.jsat.2020.108061_bb0010","doi-asserted-by":"crossref","first-page":"686","DOI":"10.2105\/AJPH.2016.303061","article-title":"Increasing benzodiazepine prescriptions and overdose mortality in the United States, 1996-2013","volume":"106","author":"Bachhuber","year":"2016","journal-title":"American Journal of Public Health"},{"issue":"2\u20133","key":"10.1016\/j.jsat.2020.108061_bb0015","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.drugalcdep.2007.04.009","article-title":"Non-medical use, abuse and dependence on sedatives and tranquilizers among U.S. adults: Psychiatric and socio-demographic correlates","volume":"90","author":"Becker","year":"2007","journal-title":"Drug and Alcohol Dependence"},{"issue":"3","key":"10.1016\/j.jsat.2020.108061_bb0020","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jsat.2012.07.013","article-title":"Development and initial evaluation of the brief addiction monitor (BAM)","volume":"44","author":"Cacciola","year":"2013","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"1\u20133","key":"10.1016\/j.jsat.2020.108061_bb0025","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jad.2008.03.014","article-title":"Validation of a brief measure of anxiety-related severity and impairment: The overall anxiety severity and impairment scale (OASIS)","volume":"112","author":"Campbell-Sills","year":"2009","journal-title":"Journal of Affective Disorders"},{"key":"10.1016\/j.jsat.2020.108061_bb0030","unstructured":"Center for Behavioral Health Statistics and Quality. (2019). 2018 National Survey on Drug Use and Health: Detailed Tables. Substance Abusde and Mental Health Services Administration, Rockville, MD."},{"issue":"2","key":"10.1016\/j.jsat.2020.108061_bb0035","first-page":"129","article-title":"Pain assessment: Global use of the brief pain inventory","volume":"23","author":"Cleeland","year":"1994","journal-title":"Annals of the Academy of Medicine Singapore"},{"key":"10.1016\/j.jsat.2020.108061_bb0040","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1037\/1040-3590.4.2.123","article-title":"Development and validation of a three dimensional measure of drinking motives","volume":"4","author":"Cooper","year":"1992","journal-title":"Psychological Assessment"},{"issue":"2","key":"10.1016\/j.jsat.2020.108061_bb0045","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/ADM.0000000000000291","article-title":"\u201cShould patients with substance use disorders be prescribed benzodiazepines?\u201d no","volume":"11","author":"DuPont","year":"2017","journal-title":"Journal of Addiction Medicine"},{"issue":"4","key":"10.1016\/j.jsat.2020.108061_bb0050","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jsat.2009.03.006","article-title":"Self-perceived motivation for benzodiazepine use and behavior related to benzodiazepine use among opiate-dependent patients","volume":"37","author":"Fatseas","year":"2009","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"5","key":"10.1016\/j.jsat.2020.108061_bb0055","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1046\/j.1360-0443.2002.00098.x","article-title":"Sedative use and misuse in the United States","volume":"97","author":"Goodwin","year":"2002","journal-title":"Addiction"},{"issue":"4","key":"10.1016\/j.jsat.2020.108061_bb0060","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3810\/pgm.2013.07.2684","article-title":"Risks, management, and monitoring of combination opioid, benzodiazepines, and\/or alcohol use","volume":"125","author":"Gudin","year":"2013","journal-title":"Postgraduate Medicine"},{"key":"10.1016\/j.jsat.2020.108061_bb0065","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap) - a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"Journal of Biomedical Informatics"},{"issue":"7","key":"10.1016\/j.jsat.2020.108061_bb0070","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.4088\/JCP.v67n0708","article-title":"Prevalence, correlates, and comorbidity of nonmedical prescription drug use and drug use disorders in the United States: Results of the National Epidemiologic Survey on Alcohol and Related Conditions","volume":"67","author":"Huang","year":"2006","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.jsat.2020.108061_bb0075","article-title":"Brief interventions targeting long-term benzodiazepine and z-drug use in primary care: A systematic review and meta-analysis","author":"Lynch","year":"2020","journal-title":"Addiction, online ahead of print."},{"issue":"6","key":"10.1016\/j.jsat.2020.108061_bb0080","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/ajad.12765","article-title":"Nonmedical benzodiazepine use in adults with alcohol use disorder: The role of anxiety sensitivity and polysubstance use","volume":"27","author":"McHugh","year":"2018","journal-title":"American Journal on Addictions"},{"issue":"3","key":"10.1016\/j.jsat.2020.108061_bb0085","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1093\/schbul\/21.3.367","article-title":"Expectations and motives for substance use in schizophrenia","volume":"21","author":"Mueser","year":"1995","journal-title":"Schizophrenia Bulletin"},{"key":"10.1016\/j.jsat.2020.108061_bb0090","unstructured":"National Institute on Drug Abuse. (2019). Overdose death rates. Retrieved from https:\/\/www.drugabuse.gov\/related-topics\/trends-statistics\/overdose-death-rates November 25, 2019."},{"issue":"4","key":"10.1016\/j.jsat.2020.108061_bb0095","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/da.20182","article-title":"Development and validation of an overall anxiety severity and impairment scale (OASIS)","volume":"23","author":"Norman","year":"2006","journal-title":"Depression and Anxiety"},{"issue":"8","key":"10.1016\/j.jsat.2020.108061_bb0100","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.brat.2010.04.002","article-title":"Efficacy of CBT for benzodiazepine discontinuation in patients with panic disorder: Further evaluation","volume":"48","author":"Otto","year":"2010","journal-title":"Behaviour Research and Therapy"},{"issue":"10","key":"10.1016\/j.jsat.2020.108061_bb0105","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1176\/ajp.150.10.1485","article-title":"Discontinuation of benzodiazepine treatment: Efficacy of cognitive-behavioral therapy for patients with panic disorder","volume":"150","author":"Otto","year":"1993","journal-title":"American Journal of Psychaitry"},{"issue":"2","key":"10.1016\/j.jsat.2020.108061_bb0110","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/ADM.0000000000000292","article-title":"Debate: Are benzodiazepines appropriate treatments for patients with substance use disorders? Yes","volume":"11","author":"Park","year":"2017","journal-title":"Journal of Addiction Medicine"},{"issue":"12","key":"10.1016\/j.jsat.2020.108061_bb0115","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1046\/j.1360-0443.2000.951217858.x","article-title":"The nature of benzodiazepine dependence among heroin users in Sydney, Australia","volume":"95","author":"Ross","year":"2000","journal-title":"Addiction"},{"key":"10.1016\/j.jsat.2020.108061_bb0120","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jsat.2016.06.008","article-title":"Reasons for benzodiazepine use among persons seeking opioid detoxification","volume":"68","author":"Stein","year":"2016","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"10","key":"10.1016\/j.jsat.2020.108061_bb0125","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1016\/j.addbeh.2013.05.008","article-title":"Treatment or \u201chigh\u201d: Benzodiazepine use in patients on injectable heroin or oral opioids","volume":"38","author":"Vogel","year":"2013","journal-title":"Addictive Behaviors"},{"key":"10.1016\/j.jsat.2020.108061_bb0130","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.drugalcdep.2019.02.033","article-title":"The epidemiology of benzodiazepine misuse: A systematic review","volume":"200","author":"Votaw","year":"2019","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2020.108061_bb0135","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.addbeh.2018.08.010","article-title":"Nonmedical prescription sedative\/tranquilizer use in alcohol and opioid use disorders","volume":"88","author":"Votaw","year":"2019","journal-title":"Addictive Behaviors"},{"issue":"12","key":"10.1016\/j.jsat.2020.108061_bb0140","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1001\/archgenpsychiatry.2011.121","article-title":"Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: A 2-phase randomized controlled trial","volume":"68","author":"Weiss","year":"2011","journal-title":"Archives of General Psychiatry"}],"container-title":["Journal of Substance Abuse Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547220303172?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547220303172?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:51:50Z","timestamp":1760039510000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740547220303172"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":28,"alternative-id":["S0740547220303172"],"URL":"https:\/\/doi.org\/10.1016\/j.jsat.2020.108061","relation":{},"ISSN":["0740-5472"],"issn-type":[{"value":"0740-5472","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Benzodiazepine misuse in adults with alcohol use disorder: Prevalence, motives and patterns of use","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Abuse Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsat.2020.108061","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108061"}}